Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$339,714
+$46,103 QoQ
Shares Held
1,350
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#3,509
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds $10,194,826 across 8 Drug Manufacturers - General names. ABBV ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
|
548,700 | $7,429,398 | |
| 2 | PFE |
Pfizer Inc
|
25,000 | $602,000 | |
| 3 | GRFS |
Grifols SA
|
77,728 | $550,314 | |
| 4 | LLY |
ELI LILLY & Co
|
350 | $419,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,700 | $346,950 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
1,350 | $339,714 | |
| 7 | JNJ |
Johnson & Johnson
|
1,000 | $253,970 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,000 | $252,680 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,714 | 1,350 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $293,611 | 1,350 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $308,461 | 1,350 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $312,579 | 1,350 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $278,430 | 1,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $314,280 | 1,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $266,550 | 1,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $394,960 | 2,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $343,040 | 2,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $364,200 | 2,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $309,940 | 2,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $298,120 | 2,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $269,460 | 2,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $318,740 | 2,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $323,220 | 2,000 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $278,754 | 2,077 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $318,113 | 2,077 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $336,702 | 2,077 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $416,625 | 3,077 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $351,871 | 3,262 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $254,791 | 2,262 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $298,903 | 2,762 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $291,662 | 2,722 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $225,719 | 2,577 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $253,009 | 2,577 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||